The Motley Fool·6h ago·Parkev Tatevosian, CfaCVS Stock Eyes Dividend Appeal Despite Regulatory HeadwindsCVS Health navigates regulatory challenges while positive developments emerge, raising questions about dividend stock valuation amid industry pressures. CVSdividend stockhealthcare stocks